Skip to main content
. 2021 Feb 24;12:2040622321993441. doi: 10.1177/2040622321993441

Table 3.

Pulmonary function in CLAD (n = 17) and non-CLAD (n = 9) patients.

Group Baseline 1 month 3 months 6 months 12 months
FEV1, % of predicted value
CLAD, mean (SD) 51.8 (16.4) 54.2 (16.7) 48.2 (18.2) 46.9 (20.8) 48.3 (21.2)
Non-CLAD, mean (SD) 74.8 (21.5) 76.1 (22.0) 78.0 (22.0) 80.3 (20.9) 77.8 (14.8)
p, difference CLAD versus non-CLAD 0.005 0.010 0.001 0.001 0.004
CLAD, mean difference (SE) 2.0 (2.0) −3.5 (3.1) −4.6 (3.7) −7.0 (5.0)
p, difference from baseline 0.339 0.274 0.233 0.196
Non-CLAD, mean difference (SE) 1.2 (2.2) 3.1 (3.5) 4.2 (3.6) 7.6 (4.9)
p, difference from baseline 0.597 0.402 0.283 0.166
FVC, % of predicted value
CLAD, mean (SD) 74.4 (14.8) 76.6 (17.4) 74.5 (18.3) 68.0 (22.3) 71.2 (16.5)
Non-CLAD (SD) 81.8 (14.1) 85.4 (15.7) 83.6 (14.4) 87.5 (16.8) 84.1 (11.2)
p, difference CLAD versus non-CLAD 0.231 0.225 0.207 0.036 0.078
CLAD, mean difference from baseline (SE) 3.5 (2.1) 0.05 (3.1) −2.5 (4.1) −4.6 (3.8)
p, difference from baseline 0.128 0.985 0.544 0.266
Non-CLAD, mean difference from baseline (SE) 3.5 (1.9) 1.7 (2.2) 5.6 (3.2) 5.8 (2.6)
p, difference from baseline 0.112 0.458 0.119 0.058

CLAD, chronic lung allograft dysfunction; FEV1, forced expiratory volume in first second; FVC, forced vital capacity; SD, standard deviation; SE, standard error.